GeNO LLC – Trademark Portfolio

Entity Type: 16

GeNO LLC holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 9 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include GENOSYL and VERO BIOTECH. The owner is based in Cocoa, FL.

2941 Oxbow Circle

Cocoa, FL 32926

10 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

GeNO LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (9 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (5 filings)

Surgical, medical, dental and veterinary apparatus and instruments

44
Medical Services (5 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does GeNO LLC have?

GeNO LLC has 10 U.S. trademarks filed with the USPTO. Of these, 3 registered, 7 abandoned.

What trademark classes does GeNO LLC file in?

GeNO LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are GeNO LLC's most well-known trademarks?

GeNO LLC's registered trademark portfolio includes well-known marks such as GENOSYL and VERO BIOTECH. These are among 3 currently registered trademarks in the portfolio.

What is GeNO LLC's trademark registration success rate?

GeNO LLC has a 30% trademark registration rate, with 3 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.